250 related articles for article (PubMed ID: 16571812)
1. The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.
Twu KY; Noah DL; Rao P; Kuo RL; Krug RM
J Virol; 2006 Apr; 80(8):3957-65. PubMed ID: 16571812
[TBL] [Abstract][Full Text] [Related]
2. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells.
Twu KY; Kuo RL; Marklund J; Krug RM
J Virol; 2007 Aug; 81(15):8112-21. PubMed ID: 17522219
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for suppression of a host antiviral response by influenza A virus.
Das K; Ma LC; Xiao R; Radvansky B; Aramini J; Zhao L; Marklund J; Kuo RL; Twu KY; Arnold E; Krug RM; Montelione GT
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13093-8. PubMed ID: 18725644
[TBL] [Abstract][Full Text] [Related]
4. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.
Noah DL; Twu KY; Krug RM
Virology; 2003 Mar; 307(2):386-95. PubMed ID: 12667806
[TBL] [Abstract][Full Text] [Related]
5. Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells.
Kuo RL; Krug RM
J Virol; 2009 Feb; 83(4):1611-6. PubMed ID: 19052083
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus.
Ai H; Zhang L; Chang AK; Wei H; Che Y; Liu H
J Mol Model; 2014 Mar; 20(3):2142. PubMed ID: 24562912
[TBL] [Abstract][Full Text] [Related]
7. Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses.
Yin C; Khan JA; Swapna GV; Ertekin A; Krug RM; Tong L; Montelione GT
J Biol Chem; 2007 Jul; 282(28):20584-92. PubMed ID: 17475623
[TBL] [Abstract][Full Text] [Related]
8. Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds.
Kleinpeter AB; Jureka AS; Falahat SM; Green TJ; Petit CM
J Biol Chem; 2018 Sep; 293(38):14659-14668. PubMed ID: 30076219
[TBL] [Abstract][Full Text] [Related]
9. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
Li S; Min JY; Krug RM; Sen GC
Virology; 2006 May; 349(1):13-21. PubMed ID: 16466763
[TBL] [Abstract][Full Text] [Related]
10. [Development of a yeast two-hybrid screen for selection of A/H1N1 influenza NS1 non-structural protein and human CPSF30 protein interaction inhibitors].
Kong JQ; Shen JH; Huang Y; Ruan RY; Xiang B; Zheng XD; Cheng KD; Wang W
Yao Xue Xue Bao; 2010 Mar; 45(3):388-94. PubMed ID: 21351518
[TBL] [Abstract][Full Text] [Related]
11. The Short Form of the Zinc Finger Antiviral Protein Inhibits Influenza A Virus Protein Expression and Is Antagonized by the Virus-Encoded NS1.
Tang Q; Wang X; Gao G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807230
[TBL] [Abstract][Full Text] [Related]
12. Functional Evolution of Influenza Virus NS1 Protein in Currently Circulating Human 2009 Pandemic H1N1 Viruses.
Clark AM; Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637754
[TBL] [Abstract][Full Text] [Related]
13. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses.
Wang W; Krug RM
Virology; 1996 Sep; 223(1):41-50. PubMed ID: 8806538
[TBL] [Abstract][Full Text] [Related]
14. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.
Chen Z; Li Y; Krug RM
EMBO J; 1999 Apr; 18(8):2273-83. PubMed ID: 10205180
[TBL] [Abstract][Full Text] [Related]
15. Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells.
Ramos I; Carnero E; Bernal-Rubio D; Seibert CW; Westera L; García-Sastre A; Fernandez-Sesma A
J Virol; 2013 Mar; 87(5):2430-40. PubMed ID: 23255794
[TBL] [Abstract][Full Text] [Related]
16. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells.
Zhao C; Hsiang TY; Kuo RL; Krug RM
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2253-8. PubMed ID: 20133869
[TBL] [Abstract][Full Text] [Related]
17. A Second RNA-Binding Site in the NS1 Protein of Influenza B Virus.
Ma LC; Guan R; Hamilton K; Aramini JM; Mao L; Wang S; Krug RM; Montelione GT
Structure; 2016 Sep; 24(9):1562-72. PubMed ID: 27545620
[TBL] [Abstract][Full Text] [Related]
18. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode.
Chien CY; Xu Y; Xiao R; Aramini JM; Sahasrabudhe PV; Krug RM; Montelione GT
Biochemistry; 2004 Feb; 43(7):1950-62. PubMed ID: 14967035
[TBL] [Abstract][Full Text] [Related]
19. Influenza Virus NS1 Protein-RNA Interactome Reveals Intron Targeting.
Zhang L; Wang J; Muñoz-Moreno R; Kim M; Sakthivel R; Mo W; Shao D; Anantharaman A; García-Sastre A; Conrad NK; Fontoura BMA
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258002
[TBL] [Abstract][Full Text] [Related]
20. The influenza virus NS1 protein as a therapeutic target.
Engel DA
Antiviral Res; 2013 Sep; 99(3):409-16. PubMed ID: 23796981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
